Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antipsychotic Discontinuation in Alzheimer's Disease (ADAD)
NCT00417482Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 2004
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in Alzheimer's disease (AD), sponsored by New York State Psychiatric Institute. Started Aug 2004; status: completed.
02
Drugs
risperidone
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00417482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417482.